573 related articles for article (PubMed ID: 18304715)
1. Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Herkert NM; Eckert S; Eyer P; Bumm R; Weber G; Thiermann H; Worek F
Toxicology; 2008 Apr; 246(2-3):188-92. PubMed ID: 18304715
[TBL] [Abstract][Full Text] [Related]
2. In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Herkert NM; Thiermann H; Worek F
Toxicol Lett; 2011 Sep; 206(1):41-6. PubMed ID: 21414391
[TBL] [Abstract][Full Text] [Related]
3. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
Eckert S; Eyer P; Worek F
Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-treatment effect of physostigmine on soman-inhibited human erythrocyte and muscle acetylcholinesterase in vitro.
Herkert NM; Schulz S; Wille T; Thiermann H; Hatz RA; Worek F
Toxicol Appl Pharmacol; 2011 May; 253(1):7-13. PubMed ID: 21402092
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the oxime-induced reactivation of rhesus monkey, swine and guinea pig erythrocyte acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Herkert NM; Lallement G; Clarençon D; Thiermann H; Worek F
Toxicology; 2009 Apr; 258(2-3):79-83. PubMed ID: 19428926
[TBL] [Abstract][Full Text] [Related]
8. Effects of oximes on rate of decarbamylation of human red blood cell AChE measured with two different methods.
Eckert S; Eyer P; Melzer M; Thiermann H; Worek F
Biochem Pharmacol; 2008 Apr; 75(7):1561-6. PubMed ID: 18281016
[TBL] [Abstract][Full Text] [Related]
9. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the oxime-induced reactivation of erythrocyte and muscle acetylcholinesterase following inhibition by sarin or paraoxon, using a perfusion model for the real-time determination of membrane-bound acetylcholinesterase activity.
Eckert S; Eyer P; Herkert N; Bumm R; Weber G; Thiermann H; Worek F
Biochem Pharmacol; 2008 Feb; 75(3):698-703. PubMed ID: 17977518
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
12. Comparative kinetics of organophosphates and oximes with erythrocyte, muscle and brain acetylcholinesterase.
Herkert NM; Freude G; Kunz U; Thiermann H; Worek F
Toxicol Lett; 2012 Mar; 209(2):173-8. PubMed ID: 22230262
[TBL] [Abstract][Full Text] [Related]
13. Effect of different buffers on kinetic properties of human acetylcholinesterase and the interaction with organophosphates and oximes.
Wille T; Thiermann H; Worek F
Arch Toxicol; 2011 Mar; 85(3):193-8. PubMed ID: 20669006
[TBL] [Abstract][Full Text] [Related]
14. Protection of human muscle acetylcholinesterase from soman by pyridostigmine bromide.
Maselli RA; Henderson JD; Ng J; Follette D; Graves G; Wilson BW
Muscle Nerve; 2011 Apr; 43(4):591-5. PubMed ID: 21404290
[TBL] [Abstract][Full Text] [Related]
15. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
16. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of newly developed reversible inhibitors of acetylcholinesterase with commonly used pyridostigmine as pharmacological pre-treatment of soman-poisoned mice.
Kassa J; Musilek K; Koomlova M; Bajgar J
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):322-6. PubMed ID: 21981462
[TBL] [Abstract][Full Text] [Related]
18. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
19. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
20. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
